MS decreases the larger amplitude distribution in adult rats. حسب Jesús David Ayala-Rodríguez (17364296)

Data collection phases based on COVID-19 policy and public health measures. حسب Lan Li (73597)

الموضوعات:

Input parameters for the base-case analysis. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Comparison of upper and lower arch crowding between premolar extraction group and the mandibular third molar extraction groups. حسب Lijuan Liu (136685)

الموضوعات:

Matrix crosslinking decreases cell migration persistence. حسب Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. حسب Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... حسب Jordan K. Abbott (8934239)

الموضوعات:

Implementation of indication-based pricing (10^th scenario) for daratumumab and pembrolizumab. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Long COVID prevalence decreases with vaccine uptake in the U.S. حسب Manlio De Domenico (626037)

"…The measured correlations are significant (<i>p</i> < 10⁻³) in all cases and highlights that the larger the vaccine uptake the lower the prevalence of long covid, with the effect further increasing with more robust vaccination protocol. …"

Larger example of stimuli with cue relevant for Task 3. حسب Marcel F. Hinss (14675457)

Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. حسب Therese M. Gilligan (7460906)

Decrease of injuries. حسب Petr Fulin (8380320)

الموضوعات:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). حسب Jeffrey S. Stein (11689918)

CBP per cumulative year for daratumumab and pembrolizumab per vial. حسب R. J. S. D. Heine (17889199)

الموضوعات:

S4 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

S1 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات:

S5 Fig - حسب R. J. S. D. Heine (17889199)

الموضوعات: